• P-ISSN 0973-7200 E-ISSN 2454-8405
  • Follow us

Journal of Pharmaceutical Research

Article

Journal of Pharmaceutical Research

Year: 2025, Volume: 24, Issue: 1, Pages: 45-48

Original Article

Computational Screening of Heterocyclic L-Type Calcium Channel Blockers for Potential Anti-Parkinson’s Activity

Abstract

Treating cardiovascular disorders like hypertension, arrhythmias, angina pectoris, and congestive heart failure involves using calcium channel blockers that bind allosterically to Cave L-type channels in myocytes in cardiac muscle. The heterocyclic compounds like 1, 4 dihydropyridines, phenyl alkyl amines, and benzodiazepines are calcium antagonists for cardiac diseases. The receptor protein CavAb in complex with Br- Verapamil was selected as a target for studying the interaction and prediction of calcium channel blocking activity of five heterocyclic compounds based on chemical structural features. using two popular software’s, Auto Dock and PyRx. The results predicted the activity of "2-(3, 4-methoxyphenyl)-5-(2, 2-phenylethylamine)-2-propan-2-ylpentanenitrile" and was chosen as the best score -6.9 – (strong) by auto dock and -9.8 by PyRX compared to the standard verapamil. Verapamil: - PyRX: -6.5, - Auto Dock: -5.22, Higher anticipated activity compounds (strong): 1. [(3R, 4S)-1-[2-ethyl (dimethylamine)]-4 (four-methoxyphenyl)5-dihydro-3H-1-benzazepin-3-yl, -7-methylsulfanyl-2-oxo-4] Acetate: - PyRX: -7.9, 2. 2-(3,4-ethoxyphenyl) - Auto Dock: -5.37(2) Phenyl ethylamine -5-2-propane-2-ylpentanenitrile:- PyRX: -9.8 molecules with weak estimated activity - Auto Dock: -6.251. 5-dicarboxylate, 4-dihydropyridine-3, 6-dimethyl-4-(3-nitrophenyl)-1, diethyl 2, PyRX: -7.2, 2. 4'- hydroxy-3'-methoxy acetophenone, Auto Dock: -3.81 PyRX: -5.6, Auto Dock: -4.31, 3. 1,4-dihydropyridine-3,5-dicarboxylate is diethyl 2,6-dimethyl-4-(4-nitrophenyl):PyRX: -6.8, Auto Dock: -4.52.Calcium channel blockers antiparkinson's effect is under recent global investigations. The ADME parameters studied for the compound were Inhibition of CYP1A2, BBB permeability, distribution, total clearance, oral rat acute toxicity (LD50), and toxicity with Swiss-ADME software. Lead optimization by identifying a molecule's salient characteristics will contribute to toxicity and building safer analogs.

Keywords: Docking, Parkinson's, Heterocyclic, Auto dock Vina, PyRX

References

  1. Bele MS, Shaikh AL, Rex KGR, Daharia A, Kharat KT, Jha A, et al. Heterocyclic Compounds' Therapeutic Potential in Alzheimer's and Parkinson's Disease by Targeting at Mitochondrial Homeostasis and Signalling. African Journal of Biological Sciences. 2024;6(6):7573–7589. Available from: https://doi.org/10.33472/AFJBS.6.6.2024.7573-7589
  2. Cheng RCK, Tikhonov DB, Zhorov BS. Structural model for Phenylalkylamines binding to L-type calcium channels. Journal of Biological Chemistry. 2009;284(41):28332–28342. Available from: https://doi.org/10.1074/jbc.M109.027326
  3. Ponnuswamy MN, Gromiha MM, Sony SMM, Saraboji K. Conformational aspects and interaction studies of heterocyclic drugs. In: QSAR and Molecular Modeling Studies in Heterocyclic Drugs I. (Vol. 1, pp. 81-147) 2006.
  4. Tang L, El-Din TM, Swanson TM, Pryde DC, Scheuer T, Zheng N, et al. Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs. Nature. 2016;537(7618):117–121. Available from: https://doi.org/10.1038/nature19102
  5. Tang L, El-Din TMG, Swanson TM, Pryde DC, Scheuer T, Zheng N, et al. Structure of CavAb in complex with Br-verapamil. 5KMH. 2016. Available from: https://doi.org/10.2210/pdb5KMH/pdb
  6. Ounthaisong U, Tangyuenyongwatana P. Cross-docking study of flavonoids against tyrosinase enzymes using PyRX 0.8 virtual screening tool. Thai Journal of Pharmaceutical Sciences. 2017. Available from: https://www.researchgate.net/publication/316546901

Copyright

© 2024 Published by Krupanidhi College of Pharmacy. This is an open-access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/

DON'T MISS OUT!

Subscribe now for latest articles and news.